agilon health, inc. (NYSE:AGL) Shares Sold by Bridgewater Associates LP

Bridgewater Associates LP trimmed its position in shares of agilon health, inc. (NYSE:AGL) by 50.6% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 117,300 shares of the company’s stock after selling 119,990 shares during the quarter. Bridgewater Associates LP’s holdings in agilon health were worth $461,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. AQR Capital Management LLC increased its stake in shares of agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after acquiring an additional 1,316,990 shares during the last quarter. Susquehanna Fundamental Investments LLC increased its position in agilon health by 65.0% during the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after purchasing an additional 316,856 shares during the last quarter. Simplicity Wealth LLC raised its stake in agilon health by 145.1% during the second quarter. Simplicity Wealth LLC now owns 26,210 shares of the company’s stock worth $171,000 after purchasing an additional 15,515 shares during the period. Healthcare of Ontario Pension Plan Trust Fund acquired a new position in agilon health in the 2nd quarter valued at about $1,849,000. Finally, Citigroup Inc. boosted its holdings in agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after purchasing an additional 1,941,993 shares during the last quarter.

agilon health Stock Up 10.3 %

AGL opened at $2.31 on Tuesday. The business has a 50 day moving average price of $2.73 and a two-hundred day moving average price of $4.63. agilon health, inc. has a 52 week low of $1.50 and a 52 week high of $13.76. The company has a market cap of $949.70 million, a PE ratio of -2.45 and a beta of 0.60. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last issued its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The firm had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. During the same period in the previous year, the firm earned ($0.06) EPS. As a group, research analysts anticipate that agilon health, inc. will post -0.47 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on AGL shares. Evercore ISI cut their target price on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research note on Tuesday, October 8th. Benchmark restated a “buy” rating and issued a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. JMP Securities lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. TD Cowen reduced their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Finally, Bank of America cut shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a research report on Wednesday, October 2nd. Three research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, agilon health presently has an average rating of “Hold” and a consensus target price of $6.05.

Insider Activity

In other news, CEO Steven Sell purchased 20,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were acquired at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the acquisition, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. The trade was a 42.03 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 3.20% of the company’s stock.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.